LifeStance Health Group, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from LifeStance Health Group, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $33 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 92% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 10.1 times by its yearly operating cash. Higher than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.4×Over the last 3 years its own operating cash covered its investment spending (capex) 2.4 times.
Higher than 76% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$40Sales grew 66% in 3 years; of every extra $100 of sales, $40 became extra profit.
Higher than 63% of Healthcare companies in United States.
Asset Productivity Ratio
+66% / +1%In 3 years sales changed by +66% while total assets changed by +1%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
10.1×Debt due within a year is covered 10.1 times by its yearly operating cash.
Higher than 85% of Healthcare companies in United States.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 74% of Healthcare companies in United States.
Tangible Assets Ratio
33%Of every $100 the company owns, $33 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 92% of Healthcare companies in United States.
Tangible Net Worth Ratio
3%Of every $100 of net worth, $3 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 72% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
LifeStance Health Group, Inc. owes $0.32 for every $1 it owns. LifeStance Health Group, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
96.6Investors pay $96.6 for every $1 of LifeStance Health Group, Inc.'s yearly profit, higher than 90% of Healthcare companies in United States.
P/B ratio
3.23The share price is 3.23 times LifeStance Health Group, Inc.'s book value per share, higher than 58% of Healthcare companies in United States.
Market cap
$4.8 BThe total market value of all of LifeStance Health Group, Inc.'s shares at today's price (share price × number of shares), larger than 83% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.5 BWhat LifeStance Health Group, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.89Net worth divided by the number of shares. The share price of $12.56 is 3.2 times this, which is the P/B above.
Return on equity (ROE)
3.4%LifeStance Health Group, Inc. earned 3.4% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
Owes vs Owns
0.32×LifeStance Health Group, Inc. owes $0.32 for every $1 it owns (low), lower than 58% of Healthcare companies in United States.
Dividend yield
NoneLifeStance Health Group, Inc. does not currently pay a dividend.
Revenue growth
+14%Revenue rose 14% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Profit growth
Back to profitLifeStance Health Group, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
0.7%LifeStance Health Group, Inc. keeps $1 of every $100 of revenue as net profit.
Cash quality
15.1×Cash from LifeStance Health Group, Inc.'s business was 15.1× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
2.1×LifeStance Health Group, Inc.'s operating profit covered its interest costs 2.1 times in the year to Dec 2025.
Cash vs debt
Net debtLifeStance Health Group, Inc. had $226 M more debt than cash (net debt) at Dec 2025.
Questions
What is LifeStance Health Group, Inc.'s P/E ratio?
Investors pay $96.6 for every $1 of LifeStance Health Group, Inc.'s yearly profit, higher than 90% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For LifeStance Health Group, Inc.: $4.8 B ÷ $1.5 B (30 Jun 2026) = 3.2.
What is LifeStance Health Group, Inc.'s return on equity?
LifeStance Health Group, Inc. earned 3.4% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
How much does LifeStance Health Group, Inc. owe compared with what it owns?
LifeStance Health Group, Inc. owes $0.32 for every $1 it owns (low), lower than 58% of Healthcare companies in United States.
Does LifeStance Health Group, Inc. pay a dividend?
No. LifeStance Health Group, Inc. does not currently pay a dividend.
Is LifeStance Health Group, Inc.'s revenue growing?
Revenue rose 14% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.